Cargando…

In Vivo Evaluation of ECP Peptide Analogues for the Treatment of Acinetobacter baumannii Infection

Antimicrobial peptides (AMPs) are alternative therapeutics to traditional antibiotics against bacterial resistance. Our previous work identified an antimicrobial region at the N-terminus of the eosinophil cationic protein (ECP). Following structure-based analysis, a 30mer peptide (ECPep-L) was desig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Jiarui, Prats-Ejarque, Guillem, Torrent, Marc, Andreu, David, Brandenburg, Klaus, Fernández-Millán, Pablo, Boix, Ester
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8962335/ https://www.ncbi.nlm.nih.gov/pubmed/35203595 http://dx.doi.org/10.3390/biomedicines10020386

Ejemplares similares

Insight into the Antifungal Mechanism of Action of Human RNase N-terminus Derived Peptides
por: Salazar, Vivian A., et al.
Publicado: (2019)

Exploring the RNase A scaffold to combine catalytic and antimicrobial activities. Structural characterization of RNase 3/1 chimeras
por: Fernández-Millán, Pablo, et al.
Publicado: (2022)

Testing a Human Antimicrobial RNase Chimera Against Bacterial Resistance
por: Prats-Ejarque, Guillem, et al.
Publicado: (2019)

Rationally Modified Antimicrobial Peptides from the N-Terminal Domain of Human RNase 3 Show Exceptional Serum Stability
por: Sandín, Daniel, et al.
Publicado: (2021)

Insights into the Antimicrobial Mechanism of Action of Human RNase6: Structural Determinants for Bacterial Cell Agglutination and Membrane Permeation
por: Pulido, David, et al.
Publicado: (2016)

Human RNase3 immune modulation by catalytic-dependent and independent modes in a macrophage-cell line infection model
por: Lu, Lu, et al.
Publicado: (2020)

Structure-Based Design of an RNase Chimera for Antimicrobial Therapy
por: Prats-Ejarque, Guillem, et al.
Publicado: (2021)

Selective cleavage of ncRNA and antiviral activity by RNase2/EDN in THP1-induced macrophages
por: Lu, Lu, et al.
Publicado: (2022)

Evolutionary Trends in RNA Base Selectivity Within the RNase A Superfamily
por: Prats-Ejarque, Guillem, et al.
Publicado: (2019)

Ecp Programme
Publicado: (2020)

Stapling of Peptides Potentiates the Antibiotic Treatment of Acinetobacter baumannii In Vivo
por: Schouten, Gina K., et al.
Publicado: (2022)

Human Antimicrobial RNases Inhibit Intracellular Bacterial Growth and Induce Autophagy in Mycobacteria-Infected Macrophages
por: Lu, Lu, et al.
Publicado: (2019)

Connecting Peptide Physicochemical and Antimicrobial Properties by a Rational Prediction Model
por: Torrent, Marc, et al.
Publicado: (2011)

20th ECP
Publicado: (2005)

Computational screening of antimicrobial peptides for Acinetobacter baumannii
por: Majumder, Ayan, et al.
Publicado: (2019)

The first crystal structure of human RNase 6 reveals a novel substrate-binding and cleavage site arrangement
por: Prats-Ejarque, Guillem, et al.
Publicado: (2016)

Antimicrobial Peptide Cec4 Eradicates Multidrug-Resistant Acinetobacter baumannii in vitro and in vivo
por: Peng, Jian, et al.
Publicado: (2023)

ECP divisional training: plan 1996
por: Storr, Kenneth Mick
Publicado: (1996)

Time-Resolved Transcriptional Profiling of Epithelial Cells Infected by Intracellular Acinetobacter baumannii
por: Crua Asensio, Nuria, et al.
Publicado: (2021)

Antibacterial mechanism of peptide Cec4 against Acinetobacter baumannii
por: Peng, Jian, et al.
Publicado: (2019)

Regulation and directed inhibition of ECP production by human neutrophils
por: Vega-Rioja, Antonio, et al.
Publicado: (2022)

Tackling Acinetobacter baumannii
por: Granata, Guido, et al.
Publicado: (2023)

The East Control Position (E.C.P.)
por: Brianti, G
Publicado: (1961)

In Vitro and In Vivo Antimicrobial Activity of the Novel Peptide OMN6 against Multidrug-Resistant Acinetobacter baumannii
por: Michaeli, Janna, et al.
Publicado: (2022)

Cryopreservation of virulent Acinetobacter baumannii to reduce variability of in vivo studies
por: Nielsen, Travis B., et al.
Publicado: (2015)

Novel Antimicrobial Peptide “Octoprohibitin” against Multidrug Resistant Acinetobacter baumannii
por: Jayathilaka, E. H. T. Thulshan, et al.
Publicado: (2022)

An Update on the Therapeutic Potential of Antimicrobial Peptides against Acinetobacter baumannii Infections
por: Rangel, Karyne, et al.
Publicado: (2023)

The “CPC Clip Motif”: A Conserved Structural Signature for Heparin-Binding Proteins
por: Torrent, Marc, et al.
Publicado: (2012)

Multidrug-Resistant Acinetobacter baumannii
por: Abbo, Aharon, et al.
Publicado: (2005)

Multidrug-Resistant Acinetobacter baumannii
por: Krcmery, Vladimir, et al.
Publicado: (2007)

Diagnosis of Acinetobacter Baumannii Infections
por: Gozdas, Hasan T
Publicado: (2012)

Acinetobacter baumannii—The New MRSA?
por: Barrie, Alasdair, et al.
Publicado: (2016)

Glycosphingolipids Recognized by Acinetobacter baumannii
por: Madar Johansson, Miralda, et al.
Publicado: (2020)

Subunit vaccines for Acinetobacter baumannii
por: Yang, Ning, et al.
Publicado: (2023)

Effects of In vivo Emergent Tigecycline Resistance on the Pathogenic Potential of Acinetobacter baumannii
por: Hornsey, Michael, et al.
Publicado: (2018)

In Vitro and In Vivo Activity of AS101 against Carbapenem-Resistant Acinetobacter baumannii
por: Yang, Tsung-Ying, et al.
Publicado: (2021)

PKPD Modeling of the Inoculum Effect of Acinetobacter baumannii on Polymyxin B in vivo
por: Chauzy, Alexia, et al.
Publicado: (2022)

Thoughtful Discussion on Article “Antimicrobial Peptide Cec4 Eradicates Multidrug-Resistant Acinetobacter baumannii in vitro and in vivo” [Letter]
por: Hidayat, Syarif, et al.
Publicado: (2023)

Antimicrobial and Anti-Biofilm Peptide Octominin for Controlling Multidrug-Resistant Acinetobacter baumannii
por: Jayathilaka, E. H. T. Thulshan, et al.
Publicado: (2021)

Eradication of drug-resistant Acinetobacter baumannii by cell-penetrating peptide fused endolysin
por: Lim, Jeonghyun, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bmnk48vu0ehm3699c5cqm2fa5r